We previously reported the anticancer potential of MH against different breast cancer subtypes [8], demonstrating its ability to inhibit tumor growth by modulating cell cycle genes, such as cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6), and arresting the G0/G1 phase in breast cancer cells. This evidence concerns the gene CDK6 and neoplasm.